Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin‐2 - Comte, Denis; Karampetsou, Maria P.; Kis‐Toth, Katalin; Yoshida, Nobuya; Bradley, Sean J.; Kyttaris, Vasileios C.; Tsokos, George C. (Arthritis & rheumatology (Hoboken, N.J.), 2017)
Keywords: 12-O-Tetradecanoylphorbol-13-acetate; Acetic acid; CD28 antigen; CD3 antigen; CD4 antigen; CD4-Positive T-Lymphocytes - immunology; Cell differentiation; Cell proliferation; Cells, Cultured; Chronic conditions; Clinical trials; Cytokines; Dilution; Humans; Interferon; Interferon-gamma - biosynthesis; Interleukin-17 - biosynthesis; Interleukin-2 - biosynthesis; Interleukin-2 - therapeutic use; Interleukin-4 - biosynthesis; Interleukins; Ionomycin; Lupus; Lupus Erythematosus, Systemic - drug therapy; Lupus Erythematosus, Systemic - immunology; Lymphocytes; Lymphocytes T; Phosphorylation; Production methods; Signal transduction; Signaling; Stimulation; Systemic lupus erythematosus; γ-Interferon